Clari Vest Asset Management LLC Provention Bio, Inc. Transaction History

Clari Vest Asset Management LLC

  • $953 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.52 - $10.57 $384,046 - $898,090
84,966 New
84,966 $898,000
Q4 2020

Feb 09, 2021
SELL
$11.79 - $18.94 $308,898 - $496,228
-26,200 Closed
0 $0
Q3 2020

Nov 09, 2020
SELL
$10.34 - $15.2 $16,544 - $24,320
-1,600 Reduced 5.76%
26,200 $336,000
Q2 2020

Aug 12, 2020
BUY
$7.81 - $17.0 $217,118 - $472,600
27,800 New
27,800 $393,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email